Stem Cells: Legal Facts Medical Spas Should Know

October 3, 2017

The Food and Drug Administration (FDA) recently issued a warning letter to a clinic for misleading patients regarding stem cell procedures.In a related press release, Food and Drug Administration (“FDA”) Commissioner Scott Gottlieb, M.D stated that “[s]tem cell clinics that mislead vulnerable patients into believing they are being given safe, effective treatments that are in full compliance with the law are dangerously exploiting consumers and putting their health at risk[.]” According to the FDA’s website, it has not approved any stem cell-based products for use other than cord blood-derived cells.
It is well settled that the FDA does not have any control over a physician’s ability to prescribe “off-label” or conduct “experimental use” of a drug. However, physicians taking such action are subjected to the oversight of their medical boards.For more information click here to read the full article on this from ByrdAdatto.

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Regenerative Aesthetics Is Evolving. Are You Keeping Up?
    • Influx Marketing Introduces Growthstack, a New All-In-One Growth Platform Built for Med Spas
    • AbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE
    • ByrdAdatto Named to D Magazine’s 2026 Best Lawyers in Dallas List
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems